Amgen, the World's Biggest Biotechnology Group: The Competitive Strategies
|
Code : COM0110
|
Region : USA
|
||||
 |
 |
 |
 OR |
||
|
Amgen: The Making of the Biotechnology Behemoth Amgen was founded on April 8th 1980 as AMGen (Applied Molecular Genetics Inc.) in California (USA) by a small group of venture capitalists led by Bill Bowes and wit hGeorge B.Rathmann as the CEO. In 1981, it raised $19.4 million in venture capital and hired a team of scientists, who pioneered the development of products based on recombinant DNA5 and molecular biology... The Competitive Landscape, Competitors and Competitive Strategies Modern biotechnology industry uses biotechnology to discover, develop and manufacture drugs to be used for human welfare. The biotechnology industry started in a big way in 1976 when Herbert Boyer and Robert Swanson formed the company Genentech Incorporated (Genentech) to commercialise the synthesis of human insulin in bacterial cells. Thereafter, the discovery of more products led to a boomin the biotechnology industry. By the end of 1981, more than 80 biotechnology companies had been established in the US alone... Amgen's Strategies to Maintain its Leadership With a market capitalization of nearly $100 billion, Amgen is at a striking distance of global pharmaceutical majors. In 2005 Amgen announced the plans of acquiring Abgenix, added 6 new products in its pipeline and set up new manufacturing sites. The acquisition of Abgenix gave Amgen full rights to the experimental drug panitumumab... |
|
| For Case Books
Click Here >> For Case eBooks Click Here >> |
|
